Abstract
Several studies have suggested that prolonged use of oral contraceptives may increase a woman's risk of developing malignant melanoma. In the Royal College of General Practitioners' Oral Contraception Study, 31 cases of malignant melanoma (code 172--International Classification of Diseases, 8th Revision) have been reported among ever-users and 27 cases among never-users. The risk ratio (RR) (indirectly standardised for age, parity, social class and smoking) was 0.92 (95% confidence interval (CI) 0.55-1.54). There was no significant trend with duration of oral contraceptive use, although those women who had used the pill for at least 10 years had an elevated RR of 1.77 (95% CI 0.80-3.90). The Oxford/Family Planning Association Study has recorded 15 cases among ever-users and 17 cases among never-users; the standardised risk ratio was 0.85 (95% CI 0.42-1.70). None of the rates observed in any duration of use category was materially different from those observed in never-users. The results available so far from the two studies suggest that oral contraceptive use is probably not associated with an increased risk of malignant melanoma.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adam S. A., Sheaves J. K., Wright N. H., Mosser G., Harris R. W., Vessey M. P. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer. 1981 Jul;44(1):45–50. doi: 10.1038/bjc.1981.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beral V., Evans S., Shaw H., Milton G. Oral contraceptive use and malignant melanoma in Australia. Br J Cancer. 1984 Nov;50(5):681–685. doi: 10.1038/bjc.1984.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beral V., Ramcharan S., Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer. 1977 Dec;36(6):804–809. doi: 10.1038/bjc.1977.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallagher R. P., Elwood J. M., Hill G. B., Coldman A. J., Threlfall W. J., Spinelli J. J. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study. Br J Cancer. 1985 Dec;52(6):901–907. doi: 10.1038/bjc.1985.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Helmrich S. P., Rosenberg L., Kaufman D. W., Miller D. R., Schottenfeld D., Stolley P. D., Shapiro S. Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. J Natl Cancer Inst. 1984 Mar;72(3):617–620. [PubMed] [Google Scholar]
- Holly E. A., Weiss N. S., Liff J. M. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst. 1983 May;70(5):827–831. [PubMed] [Google Scholar]
- Holman C. D., Armstrong B. K., Heenan P. J. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer. 1984 Nov;50(5):673–680. doi: 10.1038/bjc.1984.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee J. A., Strickland D. Malignant melanoma: social status and outdoor work. Br J Cancer. 1980 May;41(5):757–763. doi: 10.1038/bjc.1980.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vessey M., Doll R., Peto R., Johnson B., Wiggins P. A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci. 1976 Oct;8(4):373–427. doi: 10.1017/s0021932000010890. [DOI] [PubMed] [Google Scholar]
- Villard-Mackintosh L., Coleman M. P., Vessey M. P. The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study. Br J Cancer. 1988 Oct;58(4):507–511. doi: 10.1038/bjc.1988.252. [DOI] [PMC free article] [PubMed] [Google Scholar]